NK and NKT Cell Biology: Specificity and Redundancy of Innate Responses

NK 和 NKT 细胞生物学:先天反应的特异性和冗余

基本信息

  • 批准号:
    8006107
  • 负责人:
  • 金额:
    $ 0.8万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-01-01 至 2011-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Abstract PI: ROBERTSON, ANDREW D Project: 1R13AI091292-01 Title: NK and NKT Cell Biology: Specificity and Redundancy of Innate Responses Accession Number: 3255538 ================== NOTICE: THIS ABSTRACT WAS EXTRACTED FROM APPLICATION AND HAS NOT BEEN PROOFED BY AN SRA.WHEN THERE ARE PROBLEMS WITH THE APPLICATION SCANNING PROCESS, THE EXTRACTED TEXT MAY BE INCORRECT OR INCOMPLETE. ================== This proposal requests support for a Keystone Symposia meeting entitled NK and NKT Cell Biology: Specificity and Redundancy of Innate Responses, organized by James P. Di Santo, Eleanor M. Riley and Mitchell Kronenberg, which will be held in Breckenridge, Colorado from January 9 - 14, 2011. Our knowledge base in innate immunity has exploded over the past decade, and our understanding of innate immune mechanisms will soon impact in the clinics. Nevertheless, we still have much to learn about how NK cells and NKT cells shape innate and adaptive immune responses. This meeting will address issues related to the biological roles of these two specialized innate lymphocyte populations by bringing together NK and NKT cell experts to discuss their latest cutting-edge results on topics including NK/NKT development; NK/NKT cell- ligand recognition; NK/NKT activation and "crosstalk"; and roles for NK/NKT cells as both effectors and regulators of the immune response in inflammatory disease, infection and cancer. This "confrontation" between NK cell and NKT cell biologists should promote a lively forum for discussion and debate about the specificity and redundancy of NK/NKT cell responses, and can hopefully lead to new collaborations to help advance our understanding of the biological roles of these important innate mediators. In fact, this meeting is the only international meeting that brings together the world's leading experts on NK and NKT cell biology in a forum that is uniquely devoted to understanding the "crosstalk" between these two innate lymphocyte subsets. This meeting will address many questions related to fundamental mechanisms involved in the activation and regulation of immune responses to infectious pathogens. Moreover, understanding NK and NKT cell biology has broad implications, and therefore multiple, diverse plenary sessions will be devoted to the study of these two cell types, encompassing everything from signaling and development to whole organ studies of immune responses in the context of infection, autoimmunity and cancer.
描述(由申请人提供): 摘要 PI:ROBERTSON,ANDREW D 项目:1 R13 AI 091292 -01标题:NK和NKT细胞生物学:先天应答的特异性和重复性登录号:3255538 ================== 注意事项:本摘要摘自应用程序,未经SRA验证。当应用程序扫描过程出现问题时,提取的文本可能不正确或不完整。 ================== 该提案请求支持由James P. Di Santo、Eleanor M.莱利和米切尔克罗嫩伯格,这将是在布雷肯里奇,科罗拉多从2011年1月9日至14日举行。在过去的十年里,我们在先天免疫方面的知识基础已经爆炸式增长,我们对先天免疫机制的理解将很快影响临床。尽管如此,我们仍然有很多关于NK细胞和NKT细胞如何形成先天性和适应性免疫反应的知识。本次会议将解决与这两个专门的先天淋巴细胞群体的生物学作用有关的问题,将NK和NKT细胞专家聚集在一起,讨论他们最新的前沿成果,主题包括NK/NKT发展; NK/NKT细胞-配体识别; NK/NKT活化和“串扰”;以及NK/NKT细胞作为炎症性疾病,感染和癌症免疫反应的效应器和调节器的作用。NK细胞和NKT细胞生物学家之间的这种“对抗”应该促进一个活跃的论坛,讨论和辩论NK/NKT细胞反应的特异性和冗余性,并有望导致新的合作,以帮助我们进一步了解这些重要的先天介质的生物学作用。事实上,这次会议是唯一一次将世界领先的NK和NKT细胞生物学专家聚集在一个论坛上的国际会议,该论坛专门致力于了解这两种先天淋巴细胞亚群之间的“串扰”。本次会议将解决许多有关的基本机制参与激活和调节免疫反应的传染性病原体的问题。此外,了解NK和NKT细胞生物学具有广泛的意义,因此多个不同的全体会议将致力于这两种细胞类型的研究,包括从信号传导和发育到感染,自身免疫和癌症背景下免疫反应的整个器官研究。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ANDREW D ROBERTSON其他文献

ANDREW D ROBERTSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ANDREW D ROBERTSON', 18)}}的其他基金

Mechanisms of Cardiac Growth, Death and Regeneration
心脏生长、死亡和再生的机制
  • 批准号:
    8056942
  • 财政年份:
    2011
  • 资助金额:
    $ 0.8万
  • 项目类别:
Environmental Epigenomics and Disease Susceptibility
环境表观基因组学和疾病易感性
  • 批准号:
    8130161
  • 财政年份:
    2011
  • 资助金额:
    $ 0.8万
  • 项目类别:
Mycobacteria: Physiology, Metabolism and Pathogenesis - Back to the Basics
分枝杆菌:生理学、代谢和发病机制 - 回到基础
  • 批准号:
    8055811
  • 财政年份:
    2011
  • 资助金额:
    $ 0.8万
  • 项目类别:
Immunity in the Respiratory Tract: Challenges of the Lung Environment
呼吸道免疫:肺部环境的挑战
  • 批准号:
    8057229
  • 财政年份:
    2011
  • 资助金额:
    $ 0.8万
  • 项目类别:
Hematopoiesis
造血作用
  • 批准号:
    8121912
  • 财政年份:
    2011
  • 资助金额:
    $ 0.8万
  • 项目类别:
Pathogenesis of Influenza: Virus-Host Interactions
流感的发病机制:病毒与宿主的相互作用
  • 批准号:
    8128073
  • 财政年份:
    2011
  • 资助金额:
    $ 0.8万
  • 项目类别:
Drugs from Bugs: The Anti-Inflammatory Drugs of Tomorrow
昆虫药物:明天的抗炎药物
  • 批准号:
    8124051
  • 财政年份:
    2011
  • 资助金额:
    $ 0.8万
  • 项目类别:
Immunoregulatory Networks
免疫调节网络
  • 批准号:
    8121921
  • 财政年份:
    2011
  • 资助金额:
    $ 0.8万
  • 项目类别:
Tuberculosis: Immunology, Cell Biology and Novel Vaccination Strategies
结核病:免疫学、细胞生物学和新型疫苗接种策略
  • 批准号:
    8055809
  • 财政年份:
    2011
  • 资助金额:
    $ 0.8万
  • 项目类别:
MicroRNAs and Human Disease - Olson, Chair
MicroRNA 与人类疾病 - Olson,主席
  • 批准号:
    8061929
  • 财政年份:
    2011
  • 资助金额:
    $ 0.8万
  • 项目类别:

相似海外基金

Thymus antibody-secreting cells: major players in autoimmunity.
胸腺抗体分泌细胞:自身免疫的主要参与者。
  • 批准号:
    502578
  • 财政年份:
    2024
  • 资助金额:
    $ 0.8万
  • 项目类别:
B cell development, autoimmunity and immune regulation
B 细胞发育、自身免疫和免疫调节
  • 批准号:
    MR/Y033701/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.8万
  • 项目类别:
    Research Grant
Applying advanced understanding of CTLA-4 function to optimise therapies for autoimmunity
应用对 CTLA-4 功能的深入理解来优化自身免疫疗法
  • 批准号:
    MR/Y001273/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.8万
  • 项目类别:
    Research Grant
MUC16 (CA125) mutations promote fibrosis and autoimmunity in systemic sclerosis
MUC16 (CA125) 突变促进系统性硬化症的纤维化和自身免疫
  • 批准号:
    478933
  • 财政年份:
    2023
  • 资助金额:
    $ 0.8万
  • 项目类别:
    Operating Grants
Development of serologic test for early risk stratification of islet autoimmunity in genetically predisposed T1D individuals
开发用于遗传易感性 T1D 个体胰岛自身免疫早期风险分层的血清学检测
  • 批准号:
    10760885
  • 财政年份:
    2023
  • 资助金额:
    $ 0.8万
  • 项目类别:
Mechanisms of New-Onset Autoimmunity/Longitudinal Immune Systems Analysis (MONA-LISA)
新发自身免疫/纵向免疫系统分析(MONA-LISA)的机制
  • 批准号:
    10655219
  • 财政年份:
    2023
  • 资助金额:
    $ 0.8万
  • 项目类别:
Autoimmunity-Associated B Cells in Lupus Nephritis
狼疮性肾炎中自身免疫相关的 B 细胞
  • 批准号:
    10582053
  • 财政年份:
    2023
  • 资助金额:
    $ 0.8万
  • 项目类别:
Heparan sulfate as a platform to boost regulatory T cell suppression of autoimmunity
硫酸乙酰肝素作为增强调节性 T 细胞抑制自身免疫的平台
  • 批准号:
    490663
  • 财政年份:
    2023
  • 资助金额:
    $ 0.8万
  • 项目类别:
    Operating Grants
The interplay of sex hormones and chromosomes dictates pathogenicity in progressive CNS autoimmunity.
性激素和染色体的相互作用决定了进行性中枢神经系统自身免疫的致病性。
  • 批准号:
    488982
  • 财政年份:
    2023
  • 资助金额:
    $ 0.8万
  • 项目类别:
    Operating Grants
Understanding autoimmunity: Why do B cells sometimes attack our tissues instead of protecting us from infections?
了解自身免疫:为什么 B 细胞有时会攻击我们的组织而不是保护我们免受感染?
  • 批准号:
    2889164
  • 财政年份:
    2023
  • 资助金额:
    $ 0.8万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了